Chem-tox informatics: Data mining using a medicinal chemistry building block approach

Current Opinion in Drug Discovery and Development

Volumn 4, Issue 1, 2001, Pages 92-101

  Johnson, D E ^a   Blower P E , Jr ^a   Myatt, G J ^a   Wolfgang, G H I ^a  

^a ddplatform LLC   (United States)

Author keywords

Chemoinformatics; Computational toxicology; Data mining; Molecular descriptors

Indexed keywords

DATA BASE; DRUG STRUCTURE; DRUG TOXICITY; INFORMATION SCIENCE; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; COMPUTER SIMULATION; DATABASES, FACTUAL; DRUG TOXICITY; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MEDICAL INFORMATICS COMPUTING; PHARMACEUTICAL PREPARATIONS;

EID: 0035153841     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Managing the discovery/development interface
2. Success rates for new drugs entering clinical testing in the United States
3. Predicting human safety: Screening and computational approaches
4. Computational toxicology and virtual development in drug design
5. A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software
6. Chemoinformatics-similarity and diversity in chemical libraries
7. Chemoinformatics - A new name for an old problem?
8. Chemoinformatic - Predicting the physicochemical properties of 'drug-like' molecules
9. Strategies and recent technologies in drug discovery
10. Chemical similarity searching
11. Lead discovery using stochastic cluster analysis (SCA): A new method for clustering structurally similar compounds
12. Use of structure activity data to compare structure based clustering methods and descriptors for use in compound selection
13. Similarity searching in databases of chemical structures
14. Similarity searching in the development of new bioactive compounds: An application
15. Can we learn to distinguish between 'drug-like' and 'nondrug-like' molecules?
16. A scoring scheme for discriminating between drugs and nondrugs
17. Random or rational design? Evaluation of diverse compound subsets from chemical structure databases
18. Molecular diversity and representativity in chemical databases
19. Chemistry space metrics in diversity analysis, library design, and compound selection
20. Stochastic algorithms for maximizing molecular diversity
21. Experimental designs for selecting molecules from large chemical databases
22. Rapid quantification of molecular diversity for selective database acquisition
23. Use of statistical and neural net approaches in predicting toxicity of chemicals
24. Similarity searching in files of three-dimensional chemical structures-alignment of molecular electrostatic potential fields with a genetic algorithm
25. A genetic algorithm for flexible molecular overlay and pharmacophore elucidation
26. Rational combinatorial library design. 3. Simulated annealing guided evaluation (SAGE) of molecular diversity: A novel computational tool for universal library design and database mining
27. Binary formal inference-based recursive modeling using multiple atom and physicochemical property class pair and torsion descriptors as decision criteria
28. Analysis of large structure/biological activity data sets using recursive partitioning
29. Clustering of large databases of compounds: Using MDL 'keys' as structural descriptors
30. Similarity searching on CAS registry substances. 2. 2D structural similarity
31. Diversity analysis of 14,156 molecules tested by the National Cancer Institute for anti-HIV activity using the quantitative structure-activity relational expert system MCASE
32. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE
33. Atom pairs as molecular features in structure-activity studies: Definitions and applications
34. Topological torsions: A new molecular descriptor for SAR applications comparison with other descriptors
35. Chemical similarity using physiochemical property descriptors
36. Stigmata: An algorithm to determine structural commonalties in diverse datasets
37. A method for visualizing recurrent topological substructures in sets of active molecules
38. Similarity searching on CAS registry substances. 1. Global molecular property and generic atom triangle geometric searching
39. Chemical similarity using geometric atom pair descriptors
40. Diversity profiling and design using 3D pharmacophores: Pharmacophore-derived queries (PDQ)
41. A new method for rapid characterization of molecular shape: Applications in drug design
42. A fast and efficient method for 2D and 3D molecular shape description
43. Similarity searching in files of three-dimensional chemical structures: Comparison of fragment-based measures of shape similarity
44. New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures
45. Topological indices: Their nature and mutual relatedness
46. A hierarchical approach to the development of QSAR models using topological, geometrical and quantum chemical parameters
47. Shape indexes of orders one and three from molecular graphs
48. Molecular diversity in chemical databases: Comparison of medicinal chemistry knowledge bases and databases of commercially available chemicals
49. Similarity searching and clustering of chemical structure databases using molecular property data
50. Similarity searching in files of three-dimensional chemical structures: Evaluation of the EVA descriptor and combination of ranking using data fusion
51. SLASH: A program for analyzing the functional groups in molecules
52. Characterizing the geometric diversity of functional groups in chemical databases
53. The properties of known drugs. 1. Molecular frameworks
54. RECAP Retrosynthetic combinatorial analysis procedure: A powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry
55. LeadScope™: Software for exploring large sets of screening data
56. Computer-aided prediction of drug toxicity in high-throughput screening
57. Computational predictive programs (expert systems) in toxicology
58. Application of SAR methods to non-congeneric databases associated with carcinogenicity and mutagenicity: Issues and approaches
59. Structure-based methods for predicting mutagenicity and carcinogenicity: Are we there yet?
60. The development and validation of expert systems for predicting toxicity
61. Computer software for risk assessment
62. Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR
63. Use of SAR in computer-assisted prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program
64. The first US National Toxicology Program exercise on the prediction of rodent carcinogenicity: Definitive results
65. Prediction of Salmonella mutagenicity
66. QSTR applications in acute, chronic, and developmental toxicity, and carcinogenicity
67. Development, characterization and application of predictive toxicology models
68. Identification of structural features and associated mechanisms of action for carcinogens in rats
69. A modification of Tanimoto's similarity index for binary strings
70. The discovery-development interface has become the new interfacial phenomenon